Caris Life Sciences, Inc. (CAI)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Molecular Profiling Services	349.12M	Log In
Molecular Profiling Services Growth	25.24%	Log In
Pharma Research and Development Services	63.15M	Log In
Pharma Research and Development Services Growth	130.62%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
United States	401.84M	Log In
United States Growth	36.95%	Log In
International	10.42M	Log In
International Growth	-18.05%	Log In